NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)
This grant funds early phase clinical trials focused on natural products.
About this program
The NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award supports innovative research that aims to evaluate the safety and efficacy of natural products in clinical settings. This grant is designed for researchers and institutions that are conducting early phase clinical trials, specifically those that involve natural products. The phased approach allows for flexibility in research design and implementation, facilitating the exploration of promising natural interventions. Eligible applicants include academic institutions, nonprofit organizations, and other research entities that have the capacity to conduct clinical trials. The grant encourages collaboration among researchers and institutions to enhance the quality and impact of the research. By providing funding for these trials, the NCCIH aims to advance the understanding of natural products and their potential therapeutic benefits in various health conditions.
Eligibility
Academic institutions, nonprofit organizations, and research entities capable of conducting clinical trials.